Ilico Genetics
Santiago, CL · Founded 2020 · 5 employees on LinkedIn · 2 known investors
Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods. The company serves gastroenterologists and patients in the oncology diagnostics space, with a platform technology applicable to precision medicine and disease prevention.
Founders & leadership
Ilico Genetics was founded in 2020 by Alejandro Corvalán.
Investors · 2
Also in the syndicate · 1
Life Science Greenhouse Investments
Funding
SEC filings, press & company announcements- Undisclosed amountSAFE roundSep 2023
Life Science Greenhouse Investments
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Ilico Genetics do?
- Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods. The company serves gastroenterologists and patients in the oncology diagnostics space, with a platform technology applicable to precision medicine and disease prevention.
- Who founded Ilico Genetics?
- Ilico Genetics was founded by Alejandro Corvalán in 2020.
- Who are Ilico Genetics's investors?
- Ilico Genetics's investors include Life Sciences Greenhouse Investments.
- Where is Ilico Genetics headquartered?
- Ilico Genetics is headquartered in Santiago, CL.